{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:11:10Z","timestamp":1790619070827,"version":"4.1.0"},"reference-count":55,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The primary infection of Epstein-Barr virus (EBV) may result in fatal infectious mononucleosis or hemophagocytic syndrome (HPS) in 2 diseases; that is, X-linked lymphoproliferative disorder (XLP) and hemophagocytic lymphohistiocytosis (HLH). XLP is linked to mutations of the SAP\/SH2D1A gene with dysregulated T-cell activation in response to EBV infection. Patients with sporadic HLH, however, usually have no mutation of the SAP\/SH2D1A gene, and EBV latent membrane protein-1 (LMP1) can up-regulate Th1 cytokines in EBV-infected T cells. Since both diseases share common manifestations of HPS, it is important to clarify whether a cross-talk exists between signaling lymphocyte activation molecule (SLAM)\u2013associated protein (SAP) and LMP1-mediated pathways to explain the common pathogenesis of HPS. In this study, no mutation of the SAP\/SH2D1A gene at exon 2\/3 was detected in 7 HLH cases. Interestingly, EBV LMP1 could transcriptionally inhibit the expression of SAP\/SH2D1A and activate downstream molecules ERK and interferon-\u03b3 (IFN-\u03b3). LMP1-mediated SAP\/ERK\/IFN-\u03b3 signals appear to act via the TNF receptor\u2013associated factor (TRAF)2,5\/nuclear factor \u03baB (NF-\u03baB) pathway, since dominantnegative TRAF2\/5 and NF-\u03baB inhibitor could rescue SAP expression and downregulate IFN-\u03b3. Although HLH is genetically distinct from XLP, our data suggest that both diseases share a common signal pathway, through either the mutation or LMP1-mediated suppression of the SAP gene, leading to overt T-cell activation and enhanced Th1 cytokine secretion in response to EBV infection.<\/jats:p>","DOI":"10.1182\/blood-2005-04-1406","type":"journal-article","created":{"date-parts":[[2005,7,8]],"date-time":"2005-07-08T00:33:39Z","timestamp":1120782819000},"page":"3090-3096","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome"],"prefix":"10.1182","volume":"106","author":[{"given":"Huai-Chia","family":"Chuang","sequence":"first","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ding","family":"Lay","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chuan","family":"Hsieh","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ching","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chang","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-En","family":"Chuang","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ih-Jen","family":"Su","sequence":"additional","affiliation":[{"name":"From the Divisions of Clinical Research and Cancer Research, National Health Research Institutes, Taipei, Taiwan; the Institute of Basic Medical Sciences, the Department of Microbiology and Immunology, and the Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021215432902100_REF1","unstructured":"Henle W, Henle G. The relation between the Epstein-Barr virus and infectious mononucleosis, Burkitt's lymphoma and cancer of the postnasal space. East Afr Med J.1969;46: 402-406."},{"key":"2020021215432902100_REF2","doi-asserted-by":"crossref","unstructured":"Su IJ, Chen JY. The role of Epstein-Barr virus in lymphoid malignancies. Crit Rev Oncol Hematol.1997;26: 25-41.","DOI":"10.1016\/S1040-8428(97)00008-5"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Rickinson AB. Epstein-Barr virus in action in vivo. N Engl J Med.1998;338: 1461-1463.","DOI":"10.1056\/NEJM199805143382011"},{"key":"2020021215432902100_REF4","doi-asserted-by":"crossref","unstructured":"Cohen JI. Epstein-Barr virus infection. N Engl J Med.2000;343: 481-492.","DOI":"10.1056\/NEJM200008173430707"},{"key":"2020021215432902100_REF5","unstructured":"Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol.1994;144: 1219-1225."},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Su IJ, Wang CH, Cheng AL, Chen RL. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma.1995;19: 401-406.","DOI":"10.3109\/10428199509112197"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med.1988;318: 733-741.","DOI":"10.1056\/NEJM198803243181203"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Falini B, Pileri S, De Solas I, et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood.1990;75: 434-444.","DOI":"10.1182\/blood.V75.2.434.434"},{"key":"2020021215432902100_REF9","doi-asserted-by":"crossref","unstructured":"Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest.1993;92: 1444-1450.","DOI":"10.1172\/JCI116721"},{"key":"2020021215432902100_REF10","doi-asserted-by":"crossref","unstructured":"Harrington DS, Weisenburger DD, Purtilo DT. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer.1987;59: 1419-1429.","DOI":"10.1002\/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO;2-P"},{"key":"2020021215432902100_REF11","unstructured":"Masucci MG, Szigeti R, Ernberg I, et al. Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Cancer Res.1981;41: 4284-4291."},{"key":"2020021215432902100_REF12","doi-asserted-by":"crossref","unstructured":"Falk K, Ernberg I, Sakthivel R, et al. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis. Int J Cancer.1990;46: 976-984.","DOI":"10.1002\/ijc.2910460605"},{"key":"2020021215432902100_REF13","doi-asserted-by":"crossref","unstructured":"Lindsten T, Seeley JK, Ballow M, et al. Immune deficiency in the X-linked lymphoproliferative syndrome, II: immunoregulatory T cell defects. J Immunol.1982;129: 2536-2540.","DOI":"10.4049\/jimmunol.129.6.2536"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Harada S, Sakamoto K, Seeley JK, et al. Immune deficiency in the X-linked lymphoproliferative syndrome, I: Epstein-Barr virus-specific defects. J Immunol.1982;129: 2532-2535.","DOI":"10.4049\/jimmunol.129.6.2532"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Nakamura H, Zarycki J, Sullivan JL, Jung JU. Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndrome. J Immunol.2001;167: 2657-2665.","DOI":"10.4049\/jimmunol.167.5.2657"},{"key":"2020021215432902100_REF16","doi-asserted-by":"crossref","unstructured":"Okano M, Gross TG. Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol.1996;53: 111-115.","DOI":"10.1002\/(SICI)1096-8652(199610)53:2<111::AID-AJH8>3.0.CO;2-2"},{"key":"2020021215432902100_REF17","doi-asserted-by":"crossref","unstructured":"Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature.1998;395: 462-469.","DOI":"10.1038\/26683"},{"key":"2020021215432902100_REF18","doi-asserted-by":"crossref","unstructured":"Li SC, Gish G, Yang D, et al. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP\/SH2D1A. Curr Biol.1999;9: 1355-1362.","DOI":"10.1016\/S0960-9822(00)80080-9"},{"key":"2020021215432902100_REF19","doi-asserted-by":"crossref","unstructured":"Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet.1998;20: 129-135.","DOI":"10.1038\/2424"},{"key":"2020021215432902100_REF20","doi-asserted-by":"crossref","unstructured":"Czar MJ, Kersh EN, Mijares LA, et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A\/DSHP\/SAP. Proc Natl Acad Sci U S A.2001;98: 7449-7454.","DOI":"10.1073\/pnas.131193098"},{"key":"2020021215432902100_REF21","doi-asserted-by":"crossref","unstructured":"Howie D, Okamoto S, Rietdijk S, et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood.2002;100: 2899-2907.","DOI":"10.1182\/blood-2002-02-0445"},{"key":"2020021215432902100_REF22","doi-asserted-by":"crossref","unstructured":"Howie D, Simarro M, Sayos J, Guirado M, Sancho J, Terhorst C. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150\/SAP binding and CD150-mediated costimulation. Blood.2002;99: 957-965.","DOI":"10.1182\/blood.V99.3.957"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"Li C, Iosef C, Jia CY, Gkourasas T, Han VK, Shun-Cheng Li S. Disease-causing SAP mutants are defective in ligand binding and protein folding. Biochemistry.2003;42: 14885-14892.","DOI":"10.1021\/bi034798l"},{"key":"2020021215432902100_REF24","doi-asserted-by":"crossref","unstructured":"Shlapatska LM, Mikhalap SV, Berdova AG, et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol.2001;166: 5480-5487.","DOI":"10.4049\/jimmunol.166.9.5480"},{"key":"2020021215432902100_REF25","doi-asserted-by":"crossref","unstructured":"Wu C, Nguyen KB, Pien GC, et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol.2001;2: 410-414.","DOI":"10.1038\/87713"},{"key":"2020021215432902100_REF26","doi-asserted-by":"crossref","unstructured":"Hron JD, Caplan L, Gerth AJ, Schwartzberg PL, Peng SL. SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med.2004;200: 261-266.","DOI":"10.1084\/jem.20040526"},{"key":"2020021215432902100_REF27","doi-asserted-by":"crossref","unstructured":"Simrell CR, Margolick JB, Crabtree GR, Cossman J, Fauci AS, Jaffe ES. Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. Blood.1985;65: 1469-1476.","DOI":"10.1182\/blood.V65.6.1469.bloodjournal6561469"},{"key":"2020021215432902100_REF28","doi-asserted-by":"crossref","unstructured":"Ma X, Okamura A, Yosioka M, Ishiguro N, Kikuta H, Kobayashi K. No mutations of SAP\/SH2D1A\/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan. J Med Virol.2001;65: 358-361.","DOI":"10.1002\/jmv.2041"},{"key":"2020021215432902100_REF29","doi-asserted-by":"crossref","unstructured":"Su IJ, Hsieh HC, Lin KH, et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood.1991;77: 799-808.","DOI":"10.1182\/blood.V77.4.799.799"},{"key":"2020021215432902100_","doi-asserted-by":"crossref","unstructured":"d'Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood.1996;87: 1045-1055.","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045"},{"key":"2020021215432902100_","unstructured":"Takai K, Sanada M, Shibuya H. [Epstein-Barr virus associated natural killer cell leukemia: report of an autopsy case]. Rinsho Ketsueki.1995;36: 500-505."},{"key":"2020021215432902100_REF32","doi-asserted-by":"crossref","unstructured":"Akashi K, Mizuno S. Epstein-Barr virus-infected natural killer cell leukemia. Leuk Lymphoma.2000;40: 57-66.","DOI":"10.3109\/10428190009054881"},{"key":"2020021215432902100_REF33","doi-asserted-by":"crossref","unstructured":"Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest.1997;100: 1969-1979.","DOI":"10.1172\/JCI119728"},{"key":"2020021215432902100_REF34","doi-asserted-by":"crossref","unstructured":"Lay JD, Chuang SE, Rowe M, Su IJ. Epstein-barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: implications for the pathogenesis of hemophagocytic syndrome. J Biomed Sci.2003;10: 146-155.","DOI":"10.1159\/000068077"},{"key":"2020021215432902100_REF35","doi-asserted-by":"crossref","unstructured":"Devergne O, Hatzivassiliou E, Izumi KM, et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol.1996;16: 7098-7108.","DOI":"10.1128\/MCB.16.12.7098"},{"key":"2020021215432902100_REF36","doi-asserted-by":"crossref","unstructured":"Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol.1999;73: 1023-1035.","DOI":"10.1128\/JVI.73.2.1023-1035.1999"},{"key":"2020021215432902100_REF37","doi-asserted-by":"crossref","unstructured":"Chen RL, Su IJ, Lin KH, et al. Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis: an atypical form of Epstein-Barr virus infection. Am J Clin Pathol.1991;96: 171-176.","DOI":"10.1093\/ajcp\/96.2.171"},{"key":"2020021215432902100_REF38","doi-asserted-by":"crossref","unstructured":"Chen JS, Lin KH, Lin DT, Chen RL, Jou ST, Su IJ. Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens. Br J Haematol.1998;103: 756-762.","DOI":"10.1046\/j.1365-2141.1998.01026.x"},{"key":"2020021215432902100_REF39","doi-asserted-by":"crossref","unstructured":"Aizawa S, Nakano H, Ishida T, et al. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J Biol Chem.1997;272: 2042-2045.","DOI":"10.1074\/jbc.272.4.2042"},{"key":"2020021215432902100_REF40","doi-asserted-by":"crossref","unstructured":"Chuang SE, Yeh PY, Lu YS, et al. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol.2002;63: 1709-1716.","DOI":"10.1016\/S0006-2952(02)00931-0"},{"key":"2020021215432902100_REF41","doi-asserted-by":"crossref","unstructured":"Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell.1995;80: 389-399.","DOI":"10.1016\/0092-8674(95)90489-1"},{"key":"2020021215432902100_REF42","doi-asserted-by":"crossref","unstructured":"Horie R, Watanabe T, Ito K, et al. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol.2002;160: 1647-1654.","DOI":"10.1016\/S0002-9440(10)61112-1"},{"key":"2020021215432902100_REF43","doi-asserted-by":"crossref","unstructured":"Latour S, Gish G, Helgason CD, Humphries RK, Pawson T, Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol.2001;2: 681-690.","DOI":"10.1038\/90615"},{"key":"2020021215432902100_REF44","doi-asserted-by":"crossref","unstructured":"Mikhalap SV, Shlapatska LM, Yurchenko OV, et al. The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells. Blood.2004;104: 4063-4070.","DOI":"10.1182\/blood-2004-04-1273"},{"key":"2020021215432902100_REF45","doi-asserted-by":"crossref","unstructured":"Honda K, Kanegane H, Eguchi M, et al. Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization. Am J Hematol.2000;64: 128-132.","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<128::AID-AJH11>3.0.CO;2-#"},{"key":"2020021215432902100_REF46","doi-asserted-by":"crossref","unstructured":"Nagy N, Maeda A, Bandobashi K, et al. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation. Int J Cancer.2002;100: 433-440.","DOI":"10.1002\/ijc.10498"},{"key":"2020021215432902100_REF47","unstructured":"Chen JS, Tzeng CC, Tsao CJ, et al. Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica.1997;82: 572-576."},{"key":"2020021215432902100_REF48","doi-asserted-by":"crossref","unstructured":"Sylla BS, Murphy K, Cahir-McFarland E, Lane WS, Mosialos G, Kieff E. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B. Proc Natl Acad Sci U S A.2000;97: 7470-7475.","DOI":"10.1073\/pnas.130193097"},{"key":"2020021215432902100_REF49","doi-asserted-by":"crossref","unstructured":"Okano M, Thiele GM, Kobayashi RH, et al. Interferon-gamma in a family with X-linked lymphoproliferative syndrome with acute Epstein-Barr virus infection. J Clin Immunol.1989;9: 48-54.","DOI":"10.1007\/BF00917127"},{"key":"2020021215432902100_REF50","doi-asserted-by":"crossref","unstructured":"Loic D, Grazia A, Stuart GT, et al. SAP controls the cytolytic activity of CD8 T cells against EBV-infected cells. Blood.2005;105: 4383-4389.","DOI":"10.1182\/blood-2004-08-3269"},{"key":"2020021215432902100_REF51","doi-asserted-by":"crossref","unstructured":"Nagy N, Takahara M, Nishikawa J, et al. Wild-type p53 activates SAP expression in lymphoid cells. Oncogene.2004;23: 8563-8570.","DOI":"10.1038\/sj.onc.1207908"},{"key":"2020021215432902100_REF52","unstructured":"Okan I, Wang Y, Chen F, et al. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene.1995;11: 1027-1031."},{"key":"2020021215432902100_REF53","doi-asserted-by":"crossref","unstructured":"Fries KL, Miller WE, Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol.1996;70: 8653-8659.","DOI":"10.1128\/JVI.70.12.8653-8659.1996"},{"key":"2020021215432902100_REF54","doi-asserted-by":"crossref","unstructured":"Bishop GA, Busch LK. Molecular mechanisms of B-lymphocyte transformation by Epstein-Barr virus. Microbes Infect.2002;4: 853-857.","DOI":"10.1016\/S1286-4579(02)01605-2"},{"key":"2020021215432902100_REF55","doi-asserted-by":"crossref","unstructured":"Kehry MR. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. J Immunol.1996;156: 2345-2348.","DOI":"10.4049\/jimmunol.156.7.2345"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/9\/3090\/1636135\/zh802105003090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/9\/3090\/1636135\/zh802105003090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T18:24:06Z","timestamp":1683138246000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/9\/3090\/21947\/EpsteinBarr-virus-LMP1-inhibits-the-expression-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-04-1406","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}